comparemela.com

Latest Breaking News On - Exhibit hallsd h - Page 3 : comparemela.com

Gracell Biotechnologies to Present Data at AACR Annual Meeting 2022 Showcasing Early First-in-Human Results for GC502 in r/r B-ALL

/PRNewswire/ Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDAQ: GRCL), a global clinical-stage biopharmaceutical company dedicated to.

United statesStephanie carringtonMartina serschMarvin tangKyle evansPrnewswire gracell biotechnologies incGracell biotechnologies incOrleans convention centerExchange commissionAmerican association for cancer researchAmerican cancer societyAmerican associationCancer researchAnnual meetingChief medical officerPhasei clinical trials

Sonnet BioTherapeutics, Inc : Sonnet BioTherapeutics Announces Preclinical Data Supporting Its Bispecific Interleukin Candidates at the American Association for Cancer Research 2022 Annual Meeting

PRINCETON, NJ / ACCESSWIRE / April 8, 2022 / Sonnet BioTherapeutics Holdings, Inc., (NASDAQ:SONN) a clinical-stage company developing targeted immunotherapeutic drugs, announced today that data from preclinical

United statesNew orleansNew orleans convention centerMichaelv morabitoJohn ciniExchange commissionOrleans convention centerAmerican association for cancer researchSonnet biotherapeutics incSecurities exchangeSonnet biotherapeutics holdings incFully human albumin bindingAmerican associationCancer researchAnnual meetingScientific officer

Nuvalent Presents New Data Demonstrating Expanded Preclinical Activity with ROS1-Selective Inhibitor NVL-520 and ALK-Selective Inhibitor NVL-655 at AACR Annual Meeting 2022

NVL-520 showed strong preclinical activity against diverse ROS1 fusion partners and kinase-domain resistance mutations, as well as in a ROS1-driven model of.

United kingdomUnited statesMonikaa davareMonika davareClare keddyJames porterHenrye pelishLuc fribouletKatelyn nicholsonAnupong tangpeerachaikulNuvalent incOregon health science university school of medicineExchange commissionOrleans convention centerCompany annual report on formPrnewswire nuvalent inc

Actuate Therapeutics Announces Poster Presentations at the 2022 AACR Annual Meeting

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United statesNew orleansRhode islandBrown universityNew orleans convention centerKelseye huntingtonOrleans convention centerAmerican association for cancer researchActuate therapeutics incAmerican associationCancer researchAnnual meetingPresentation detailsMonday aprilDrug actionLevine children

Arcellx Provides Business Update and Reports Fourth Quarter and Year-End 2021 Financial Results

/PRNewswire/ Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for.

United statesUniversity of texasWhite houseDistrict of columbiaKavita patelEdward kennedyJohns hopkinsMyesha lacyIntelligent medicine acquisition corpUniversity of california los angelesSigilon therapeutics incArcellx incAmerican association for cancer research annual meetingOffice of intergovernmental affairsMary centerDrug administration

vimarsana © 2020. All Rights Reserved.